Abiopharma

🔍 Clark Thomas Eugene (Executive)

Company: GLOBAL INDUSTRIAL Co (GIC)

Report Date: 2026-08-06

Detailed Transactions and Holdings:

• Acquired 17,500 shares of Common Stock at $6.02 per share (Direct)
  Date: 2026-08-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 89,731.00 | transaction_form_type: 4
• Sold 17,500 shares of Common Stock at $39.1407 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 72,231.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 17,500 shares of Employee Stock Option (right to buy) at $6.02 per share (Derivative)
  Date: 2026-08-06 | Code: M | Expires: 2026-11-10 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The price reported in Column 4 is a weighted average sale price calculated by the broker executing the sales. These shares were sold in multiple transactions at prices ranging from $38.75 to $39.675, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
• F2: The Employee Stock Option (right to buy) granted on November 10, 2016 have a four year vesting schedule with 25% vesting on the first, second, third and fourth anniversary dates of the grant date.